Logo image of CULP

CULP INC (CULP) Stock Fundamental Analysis

NYSE:CULP - New York Stock Exchange, Inc. - US2302151053 - Common Stock - Currency: USD

4.31  -0.1 (-2.27%)

Fundamental Rating

2

Overall CULP gets a fundamental rating of 2 out of 10. We evaluated CULP against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CULP may be in some trouble as it scores bad on both profitability and health. CULP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CULP has reported negative net income.
CULP had a negative operating cash flow in the past year.
CULP had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CULP reported negative operating cash flow in multiple years.
CULP Yearly Net Income VS EBIT VS OCF VS FCFCULP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

With a Return On Assets value of -15.48%, CULP is not doing good in the industry: 82.00% of the companies in the same industry are doing better.
CULP has a worse Return On Equity (-33.14%) than 74.00% of its industry peers.
Industry RankSector Rank
ROA -15.48%
ROE -33.14%
ROIC N/A
ROA(3y)-15.55%
ROA(5y)-9.39%
ROE(3y)-28.88%
ROE(5y)-17.37%
ROIC(3y)N/A
ROIC(5y)N/A
CULP Yearly ROA, ROE, ROICCULP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

CULP has a worse Gross Margin (12.46%) than 90.00% of its industry peers.
CULP's Gross Margin has declined in the last couple of years.
CULP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.35%
GM growth 5Y-5.75%
CULP Yearly Profit, Operating, Gross MarginsCULP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

CULP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CULP has been increased compared to 1 year ago.
CULP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CULP has a worse debt to assets ratio.
CULP Yearly Shares OutstandingCULP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
CULP Yearly Total Debt VS Total AssetsCULP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.47 indicates that CULP is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.47, CULP is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.22 indicates that CULP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.22, CULP is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 2.47
ROIC/WACCN/A
WACC338.55%
CULP Yearly LT Debt VS Equity VS FCFCULP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.78 indicates that CULP should not have too much problems paying its short term obligations.
With a Current ratio value of 1.78, CULP perfoms like the industry average, outperforming 42.00% of the companies in the same industry.
CULP has a Quick Ratio of 1.78. This is a bad value and indicates that CULP is not financially healthy enough and could expect problems in meeting its short term obligations.
CULP has a worse Quick ratio (0.73) than 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.73
CULP Yearly Current Assets VS Current LiabilitesCULP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CULP have decreased strongly by -31.78% in the last year.
CULP shows a decrease in Revenue. In the last year, the revenue decreased by -5.37%.
Measured over the past years, CULP shows a decrease in Revenue. The Revenue has been decreasing by -3.60% on average per year.
EPS 1Y (TTM)-31.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.18%
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-10.23%
Revenue growth 5Y-3.6%
Sales Q2Q%-1.52%

3.2 Future

CULP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.59% yearly.
CULP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.05% yearly.
EPS Next Y118.81%
EPS Next 2Y50.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.29%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CULP Yearly Revenue VS EstimatesCULP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CULP Yearly EPS VS EstimatesCULP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CULP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 16.25, which indicates a correct valuation of CULP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CULP is on the same level as its industry peers.
CULP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.67.
Industry RankSector Rank
PE N/A
Fwd PE 16.25
CULP Price Earnings VS Forward Price EarningsCULP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CULP Per share dataCULP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CULP's earnings are expected to grow with 50.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.59%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CULP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CULP INC

NYSE:CULP (7/28/2025, 4:10:03 PM)

4.31

-0.1 (-2.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)06-25 2025-06-25/amc
Earnings (Next)09-02 2025-09-02
Inst Owners62.86%
Inst Owner Change0%
Ins Owners7.35%
Ins Owner Change6.77%
Market Cap54.13M
Analysts82.86
Price TargetN/A
Short Float %0.36%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.09%
Min EPS beat(2)-34.8%
Max EPS beat(2)50.98%
EPS beat(4)1
Avg EPS beat(4)-5.22%
Min EPS beat(4)-34.8%
Max EPS beat(4)50.98%
EPS beat(8)4
Avg EPS beat(8)1.71%
EPS beat(12)6
Avg EPS beat(12)-2.52%
EPS beat(16)7
Avg EPS beat(16)-10.09%
Revenue beat(2)0
Avg Revenue beat(2)-8.63%
Min Revenue beat(2)-8.75%
Max Revenue beat(2)-8.52%
Revenue beat(4)1
Avg Revenue beat(4)-4.64%
Min Revenue beat(4)-8.75%
Max Revenue beat(4)4.58%
Revenue beat(8)1
Avg Revenue beat(8)-3.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.88%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)85.71%
Revenue NQ rev (1m)-9.02%
Revenue NQ rev (3m)-9.02%
Revenue NY rev (1m)-6.87%
Revenue NY rev (3m)-6.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.25
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)0.27
Fwd EY6.15%
FCF(TTM)-1.64
FCFYN/A
OCF(TTM)-1.41
OCFYN/A
SpS16.98
BVpS4.59
TBVpS4.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.48%
ROE -33.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.46%
FCFM N/A
ROA(3y)-15.55%
ROA(5y)-9.39%
ROE(3y)-28.88%
ROE(5y)-17.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.35%
GM growth 5Y-5.75%
F-Score3
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.42%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.73
Altman-Z 2.47
F-Score3
WACC338.55%
ROIC/WACCN/A
Cap/Depr(3y)44.35%
Cap/Depr(5y)59.91%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.18%
EPS Next Y118.81%
EPS Next 2Y50.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-10.23%
Revenue growth 5Y-3.6%
Sales Q2Q%-1.52%
Revenue Next Year-1.29%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year196.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.62%
OCF growth 3YN/A
OCF growth 5YN/A